Basal and claudin-low carcinomas are mainly estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and human epidermal growth factor receptor 2 (HER2)-negative (triple negative). This evidence concerns the gene ERBB2 and carcinoma.